Table 1.
All (n = 36) | Males (n = 16) | Females (n = 20) | p | |
---|---|---|---|---|
Age (mean ± SD), years | 82.8 ± 7.9 | 80.1 ± 4.8 | 84.9 ± 9.3 | 0.03 |
Age, range | 70 – 101 | 70 – 90 | 70 – 101 | |
Education level (mean ± SD), years | 4.4 ± 3.9 | 5.2 ± 5.3 | 3.6 ± 2.0 | 0.426 |
ADL score (mean ± SD) | 4.1 ± 2.4 | 4.3 ± 2.5 | 3.9 ± 2.3 | 0.481 |
IADL score (mean ± SD) | 3.9 ± 3.2 | 4.4 ± 3.5 | 3.6 ± 3.1 | 0.386 |
SPMSQ score (mean ± SD) | 2.7 ± 3.4 | 2.9 ± 3.3 | 2.4 ± 2.9 | 0.808 |
Exton-Smith score (mean ± SD) | 15.3 ± 4.5 | 15.4 ± 5.0 | 15.1 ± 4.1 | 0.445 |
CIRS comorbidity score (mean ± SD) | 3.1 ± 2.1 | 3.3 ± 2.6 | 2.9 ± 1.5 | 0.854 |
MNA score (mean ± SD) | 19.2 ± 7.0 | 20.7 ± 7.9 | 18.1 ± 6.3 | 0.180 |
Drugs, n (mean ± SD) | 3.4 ± 1.9 | 3.5 ± 1.4 | 3.3 ± 2.2 | 0.539 |
Low-dose aspirin/NSAID, n (%) | 11 (30.6) | 6 (37.5) | 5 (25.0) | 0.656 |
Warfarin, n (%) | 3 (8.3) | 2 (12.5) | 1 (5.0) | 0.840 |
PPI, n (%) | 6 (16.7) | 2 (12.5) | 4 (20) | 0.881 |
MPI (mean ± SD) score | 0.39 ± 0.26 | 0.36 ± 0.27 | 0.40 ± 0.25 | 0.560 |
Mortality, n (%) | 11 (30.6) | 3 (18.8) | 8 (40.0) | 0.156 |